Welcome to this week's Chutes and Ladders, our roundup of hirings and firings throughout the industry. Please send the good word--or the bad--from your shop to Michael Gibney (email | Twitter) or Emily Mullin (email | Twitter) and we will feature it here at the end of each week.
Former Pfizer general counsel Schulman joins Alnylam's board
One-time Pfizer ($PFE) general counsel Amy Schulman has taken a step back into the biopharma arena, this time as a board member at Alnylam ($ALNY), the hot RNAi drug developer from the Boston area. Back in December, Schulman ended her 5-year stint with Pfizer--on less-than-clear terms--after being named one of Fortune's "50 Most Powerful Women in Business" and just before beginning a new position in its vaccine, cancer and consumer products business. Currently a senior lecturer at Harvard Business School, Schulman offers her counsel experience to up-and-coming Alnylam as it transitions from clinical programs to commercial operation, according to a statement from CEO John Maraganore. Release
Medical Devices > Bellerophon brought on former Amgen ($AMGN) executive Jonathan Peacock as chairman and CEO. Story Biotech > InVivo Therapeutics ($NVIV) has appointed Christopher McNulty as its new vice president of business development and investor relations. Release > Moderna Therapeutics announced Dr. Stephen Kelsey will be president of its oncology drug development company Onkaido Therapeutics. Release > Actavis ($ACT) appointed three new members to its board of directors, including its newly appointed CEO and president Brenton L. Saunders, along with Nesli Basgoz and Christopher J. Coughlin, following its acquisition of Forest ($FRX). Release > Zafgen ($ZFGN) announced Patrick Loustau as its new president. Release > Bacterin International announced the appointment of Robert Di Silvio as its president. Release > Professional Disposables International appointed Peter Cempellin as executive vice president and chief operating officer and Patrick Treacy as executive vice president of PDI and president of PDI Healthcare. Release > Histogenics Corporation has appointed Kathleen Large to vice president of clinical operations. Release > Gail Naughton has joined the board of Cytori Therapeutics. Release > BioRestorative Therapies appointed Joseph Swiader to its board of directors. Release > Proteostasis Therapeutics named Meenu Chhabra as its new CEO. Release > Prosensa brought on Willem W. van Weperen to be its chief commercial officer and Annalisa Jenkins as part of its supervisory board. Release > Nanomix appointed Brian Jung to be its new CFO. Release Pharma > Deciphera Pharmaceuticals named Oliver Rosen as its chief medical officer. Release > Paratek pharmaceuticals appointed Michael Bigham as chairman and CEO and promoted Evan Loh to become its new president and CMO. Release |
||||||||||
